Protein Kinase G Positively Regulates Proteasome-Mediated Degradation of Misfolded Proteins

Background— Proteasome functional insufficiency is implicated in a large subset of cardiovascular diseases and may play an important role in their pathogenesis. The regulation of proteasome function is poorly understood, hindering the development of effective strategies to improve proteasome function. Methods and Results— Protein kinase G (PKG) was manipulated genetically and pharmacologically in cultured cardiomyocytes. Activation of PKG increased proteasome peptidase activities, facilitated proteasome-mediated degradation of surrogate (enhanced green fluorescence protein modified by carboxyl fusion of degron CL1) and bona fide (CryABR120G) misfolded proteins, and attenuated CryABR120G overexpression–induced accumulation of ubiquitinated proteins and cellular injury. PKG inhibition elicited the opposite responses. Differences in the abundance of the key 26S proteasome subunits Rpt6 and &bgr;5 between the PKG-manipulated and control groups were not statistically significant, but the isoelectric points were shifted by PKG activation. In transgenic mice expressing a surrogate substrate (GFPdgn), PKG activation by sildenafil increased myocardial proteasome activities and significantly decreased myocardial GFPdgn protein levels. Sildenafil treatment significantly increased myocardial PKG activity and significantly reduced myocardial accumulation of CryABR120G, ubiquitin conjugates, and aberrant protein aggregates in mice with CryABR120G-based desmin-related cardiomyopathy. No discernible effect on bona fide native substrates of the ubiquitin-proteasome system was observed from PKG manipulation in vitro or in vivo. Conclusions— PKG positively regulates proteasome activities and proteasome-mediated degradation of misfolded proteins, likely through posttranslational modifications to proteasome subunits. This may be a new mechanism underlying the benefit of PKG stimulation in treating cardiac diseases. Stimulation of PKG by measures such as sildenafil administration is potentially a new therapeutic strategy to treat cardiac proteinopathies.

[1]  Xuejun Wang,et al.  Ubiquitin receptors and protein quality control. , 2013, Journal of molecular and cellular cardiology.

[2]  Xuejun Wang,et al.  Posttranslational modification and quality control. , 2013, Circulation research.

[3]  Xuejun Wang,et al.  Genetically Induced Moderate Inhibition of the Proteasome in Cardiomyocytes Exacerbates Myocardial Ischemia-Reperfusion Injury in Mice , 2012, Circulation research.

[4]  Nobel C. Zong,et al.  Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics. , 2012, American journal of physiology. Heart and circulatory physiology.

[5]  B. Gage,et al.  Effects of Phosphodiesterase Type 5 Inhibition on Systemic and Pulmonary Hemodynamics and Ventricular Function in Patients With Severe Symptomatic Aortic Stenosis , 2012, Circulation.

[6]  N. Wei,et al.  COP9 Signalosome Regulates Autophagosome Maturation , 2011, Circulation.

[7]  J. Li,et al.  Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. , 2011, The Journal of clinical investigation.

[8]  Xuejun Wang,et al.  Autophagy and p62 in Cardiac Proteinopathy , 2011, Circulation research.

[9]  J. Robbins,et al.  Atg7 Induces Basal Autophagy and Rescues Autophagic Deficiency in CryABR120G Cardiomyocytes , 2011, Circulation research.

[10]  A. Abbate,et al.  Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway. , 2011, American journal of physiology. Heart and circulatory physiology.

[11]  L. Carrier,et al.  The ubiquitin–proteasome system in cardiomyopathies , 2011, Current opinion in cardiology.

[12]  Xuejun Wang,et al.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  R. Arena,et al.  PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure: Results of a 1-Year, Prospective, Randomized, Placebo-Controlled Study , 2011, Circulation. Heart failure.

[14]  D. Kass.  Res-erection of Viagra as a heart drug. , 2011, Circulation. Heart failure.

[15]  P. Ping,et al.  Differential Regulation of Proteasome Function in Isoproterenol-Induced Cardiac Hypertrophy , 2010, Circulation research.

[16]  A. Gomes,et al.  Myocardial Ischemic Preconditioning Preserves Postischemic Function of the 26S Proteasome Through Diminished Oxidative Damage to 19S Regulatory Particle Subunits , 2010, Circulation research.

[17]  R. Tanzi,et al.  Protein Aggregates and Novel Presenilin Gene Variants in Idiopathic Dilated Cardiomyopathy , 2010, Circulation.

[18]  F. Pagani,et al.  Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies , 2010, Circulation.

[19]  C. Patterson,et al.  The Ubiquitin Proteasome System Regulates Cell Signaling and Protein Quality Control in Cardiovascular Development and Disease , 2010 .

[20]  Julio C. B. Ferreira,et al.  Ischaemic preconditioning improves proteasomal activity and increases the degradation of δPKC during reperfusion , 2009, Cardiovascular research.

[21]  浅井 光俊.  PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts , 2009 .

[22]  Suzanne Tydlacka,et al.  Differential Activities of the Ubiquitin–Proteasome System in Neurons versus Glia May Account for the Preferential Accumulation of Misfolded Proteins in Neurons , 2008, The Journal of Neuroscience.

[23]  P. Ping,et al.  Revealing the Dynamics of the 20 S Proteasome Phosphoproteome , 2008, Molecular & Cellular Proteomics.

[24]  J. Robbins,et al.  Cardiomyocyte Expression of a Polyglutamine Preamyloid Oligomer Causes Heart Failure , 2008, Circulation.

[25]  Ping Huang,et al.  Proteasome Function Is Regulated by Cyclic AMP-dependent Protein Kinase through Phosphorylation of Rpt6* , 2007, Journal of Biological Chemistry.

[26]  Manuela Zaccolo,et al.  of in The Role of the in the A Molecular for Generating cAMP and cGMP Signaling Cross-Talk Role of Phosphodiesterases and Implications for Cardiac Pathophysiology , 2007 .

[27]  K. Davies,et al.  Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations. , 2007, Journal of molecular and cellular cardiology.

[28]  P. Ping,et al.  Mapping the Murine Cardiac 26S Proteasome Complexes , 2006, Circulation research.

[29]  D. Cooper,et al.  Cyclic Guanosine Monophosphate Compartmentation in Rat Cardiac Myocytes , 2006, Circulation.

[30]  M. Hori,et al.  Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. , 2006, Biochemical and biophysical research communications.

[31]  J. Li,et al.  The FASEB Journal express article 10.1096/fj.05-3973fje. Published online September 27, 2005. , 2022 .

[32]  ElizabethMurphy,et al.  Mitochondrial Dysfunction and Apoptosis Underlie the Pathogenic Process in α-B-Crystallin Desmin-Related Cardiomyopathy , 2005 .

[33]  E. Murphy,et al.  Mitochondrial Dysfunction and Apoptosis Underlie the Pathogenic Process in α-B-Crystallin Desmin-Related Cardiomyopathy , 2005, Circulation.

[34]  Jinbao Liu,et al.  Intrasarcoplasmic Amyloidosis Impairs Proteolytic Function of Proteasomes in Cardiomyocytes by Compromising Substrate Uptake , 2005, Circulation research.

[35]  D. Kass,et al.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.

[36]  J. Saffitz,et al.  Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Schaper,et al.  Myocytes Die by Multiple Mechanisms in Failing Human Hearts , 2003, Circulation research.

[38]  Michael J Dunn,et al.  Hyperubiquitination of proteins in dilated cardiomyopathy , 2003, Proteomics.

[39]  I. Weinstein,et al.  Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G. , 2002, Molecular cancer therapeutics.

[40]  T. Hewett,et al.  Expression of R120G–αB-Crystallin Causes Aberrant Desmin and αB-Crystallin Aggregation and Cardiomyopathy in Mice , 2001 .

[41]  T. Hewett,et al.  Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. , 2001, Circulation research.

[42]  R. Huber,et al.  Proteasome beta-type subunits: unequal roles of propeptides in core particle maturation and a hierarchy of active site function. , 1999, Journal of molecular biology.

[43]  M. Prevost,et al.  A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy , 1998, Nature Genetics.

[44]  R. G. Kulka,et al.  Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae , 1998, The EMBO journal.

[45]  M. Hochstrasser,et al.  Autocatalytic Subunit Processing Couples Active Site Formation in the 20S Proteasome to Completion of Assembly , 1996, Cell.